Guus A.M.S. van Dongen

Statistics

Publications

Citations

2.4K

H-Index

Active since

1990

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Vrije Universiteit Amsterdam

University of Amsterdam

Radboud University Medical Center

Radboud University Nijmegen

Guus A.M.S. van Dongen is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, oncology, and radionuclide therapy.

Publications per year

1990–2019

Publications

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

Pieter J. Gaillard, Chantal C.M. Appeldoorn, Rick Dorland et al. · PLoS ONE · 2014 · 284 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis

David Maussang, Dennis Verzijl, Marijke van Walsum et al. · Proceedings of the National Academy of Sciences · 2006 · 234 citations · Full text

Medicine, Molecular Biology, Oncology +17

Disparity Between In Vivo EGFR Expression and <sup>89</sup>Zr-Labeled Cetuximab Uptake Assessed with PET

Hugo J.W.L. Aerts, Ludwig J. Dubois, Lars R. Perk et al. · Journal of Nuclear Medicine · 2008 · 194 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Preclinical evaluation and validation of [ <sup>18</sup> F]HX4, a promising hypoxia marker for PET imaging

Ludwig J. Dubois, Natasja G. Lieuwes, Marco H.M. Janssen et al. · Proceedings of the National Academy of Sciences · 2011 · 132 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

Pontus K.E. Börjesson, Ernst J. Postema, Jan C. Roos et al. · PubMed · 2003 · 114 citations

Pharmacy, Oncology, Radiation Oncology +17

1–5 of 37